Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Tsunezuka, Y."" wg kryterium: Wszystkie pola


Tytuł :
The Impact of Endoscopic Stapler Selection on Bleeding at the Vascular Stump in Pulmonary Artery Transection
Autorzy :
Tsunezuka Y
Tanaka N
Fujimori H
Pokaż więcej
Temat :
surgery
stapler
pulmonary artery
bleeding
Medical technology
R855-855.5
Źródło :
Medical Devices : Evidence and Research, Vol Volume 13, Pp 41-47 (2020)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/the-impact-of-endoscopic-stapler-selection-on-bleeding-at-the-vascular-peer-reviewed-article-MDER; https://doaj.org/toc/1179-1470
Dostęp URL :
https://doaj.org/article/5d49c9b645824cf79e4e4a324dd90a8d
Czasopismo naukowe
Tytuł :
[Management of Patients with Cardiac Failure Undergoing General Thoracic Surgery].
Autorzy :
Tsunezuka Y; Department of General Thoracic Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Pokaż więcej
Źródło :
Kyobu geka. The Japanese journal of thoracic surgery [Kyobu Geka] 2020 Sep; Vol. 73 (10), pp. 855-861.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Artery Disease*
Heart Diseases*
Heart Failure*/complications
Heart Failure*/therapy
Thoracic Surgery*
Humans ; Perioperative Care ; Postoperative Complications/prevention & control ; Risk Factors
Czasopismo naukowe
Tytuł :
[Improved Method of Closure of Chest Drain Wound by Barbed Suture].
Autorzy :
Tsunezuka Y; Department of General Thoracic Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Tanaka N
Fujimori H
Pokaż więcej
Źródło :
Kyobu geka. The Japanese journal of thoracic surgery [Kyobu Geka] 2020 Jul; Vol. 73 (7), pp. 539-542.
Typ publikacji :
Journal Article
MeSH Terms :
Chest Tubes*
Suture Techniques*
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Drainage ; Female ; Humans ; Male ; Middle Aged ; Sutures ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study.
Autorzy :
Fukuhara T; Miyagi Cancer Center, Natori, Japan.
Saito H; Kanagawa Cancer Center, Yokohama, Japan.
Furuya N; St. Marianna University School of Medicine, Kawasaki, Japan.
Watanabe K; Miyagi Cancer Center, Natori, Japan.
Sugawara S; Sendai Kousei Hospital, Sendai, Japan.
Iwasawa S; Chiba University, Chiba, Japan.
Tsunezuka Y; Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Yamaguchi O; Saitama Medical University International Medical Center, Hidaka, Japan.
Okada PM; Hiroshima University Hospital, Hiroshima, Japan.
Yoshimori K; Fukujuji Hospital, Tokyo, Japan.
Nakachi I; Saiseikai Utsunomiya Hospital, Utsunomiya, Japan.
Gemma PA; Nippon Medical School, Tokyo, Japan.
Azuma K; Kurume University, Kurume, Japan.
Kurimoto F; Saitama Cancer Center, Ina, Japan.
Tsubata Y; Shimane University, Shimane, Japan.
Fujita Y; National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan.
Nagashima H; Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, 2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3695, Japan.
Asai G; Okazaki City Hospital, Okazaki, Japan.
Watanabe S; Niigata University Medical and Dental Hospital, Niigata, Japan.
Miyazaki M; Suita Municipal Hospital, Suita, Japan.
Hagiwara PK; Jichi Medical University, Shimotsuke, Japan.
Nukiwa PT; Tohoku University, Sendai, Japan.
Morita PS; Kyoto University, Kyoto, Japan.
Kobayashi PK; Saitama Medical University International Medical Center, Hidaka, Japan.
Maemondo PM; Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, 2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate 028-3695, Japan. Electronic address: .
Pokaż więcej
Źródło :
EBioMedicine [EBioMedicine] 2020 Jul; Vol. 57, pp. 102861. Date of Electronic Publication: 2020 Jul 03.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323.
Autorzy :
Kozuki T; Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
Nogami N; Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
Hataji O; Department of Respiratory Medicine, Matsusaka Municipal Hospital, Matsusaka, Mie, Japan.
Tsunezuka Y; Department of General Thoracic Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Ishikawa, Japan.
Seki N; Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan.
Harada T; Department of Respiratory Medicine, Japan Community Health Care Organization Hokkaido Hospital, Toyohira-ku, Sapporo, Japan.
Fujimoto N; Department of Respiratory Medicine, Okayama Rosai Hospital, Minami-ku, Okayama-shi, Okayama, Japan.
Bessho A; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Kita-ku, Okayama-shi, Okayama, Japan.
Takamura K; Department of Respiratory Medicine, Obihiro Kosei General Hospital, Obihiro-shi, Hokkaido, Japan.
Takahashi K; Department of Respiratory Medicine, Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan.
Satouchi M; Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan.
Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Shukuya T; Department of Respiratory Medicine, Juntendo University Hospital, Bunkyo-ku, Tokyo, Japan.
Yamashita N; Clinical Research Center, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
Okamoto H; Department of Respiratory Medicine and Medical Oncology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Shinkai T; Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.; Department of Respiratory Medicine, Shonan Eastern General Hospital, Chigasaki, Kanagawa, Japan.
Pokaż więcej
Corporate Authors :
Thoracic Oncology Research Group
Źródło :
Translational lung cancer research [Transl Lung Cancer Res] 2020 Jun; Vol. 9 (3), pp. 459-470.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.
Autorzy :
Saito H; Kanagawa Cancer Center, Yokohama, Japan.
Fukuhara T; Miyagi Cancer Center, Natori, Japan.
Furuya N; St Marianna University School of Medicine, Kawasaki, Japan.
Watanabe K; Miyagi Cancer Center, Natori, Japan.
Sugawara S; Sendai Kousei Hospital, Sendai, Japan.
Iwasawa S; Chiba University, Chiba, Japan.
Tsunezuka Y; Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Yamaguchi O; Saitama Medical University, Saitama, Japan.
Okada M; Hiroshima University Hospital, Hiroshima, Japan.
Yoshimori K; Fukujuji Hospital, Tokyo, Japan.
Nakachi I; Saiseikai Utsunomiya Hospital, Utsunomiya, Japan.
Gemma A; Nippon Medical School, Tokyo, Japan.
Azuma K; Kurume University, Kurume, Japan.
Kurimoto F; Saitama Cancer Center, Saitama, Japan.
Tsubata Y; Shimane University, Shimane, Japan.
Fujita Y; National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan.
Nagashima H; Iwate Medical University School of Medicine, Morioka, Japan.
Asai G; Aichi Cancer Center Aichi Hospital, Okazaki, Japan.
Watanabe S; Niigata University Medical and Dental Hospital, Niigata, Japan.
Miyazaki M; Suita Municipal Hospital, Osaka, Japan.
Hagiwara K; Jichi Medical University, Shimotsuke, Japan.
Nukiwa T; Tohoku University, Miyagi, Japan.
Morita S; Kyoto University, Kyoto, Japan.
Kobayashi K; Saitama Medical University, Saitama, Japan.
Maemondo M; Iwate Medical University School of Medicine, Morioka, Japan. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2019 May; Vol. 20 (5), pp. 625-635. Date of Electronic Publication: 2019 Apr 08.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Bevacizumab/*administration & dosage
Carcinoma, Non-Small-Cell Lung/*drug therapy
Erlotinib Hydrochloride/*administration & dosage
Lung Neoplasms/*drug therapy
Protein Kinase Inhibitors/*administration & dosage
Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab/adverse effects ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Disease Progression ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Erlotinib Hydrochloride/adverse effects ; Female ; Humans ; Japan ; Lung Neoplasms/genetics ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Mutation ; Neoplasm Staging ; Progression-Free Survival ; Protein Kinase Inhibitors/adverse effects ; Signal Transduction ; Time Factors
Czasopismo naukowe
Tytuł :
Positron Emission Tomography in Relation to Noguchi’s Classification for Diagnosis of Peripheral Non-Small-Cell Lung Cancer 2 cm or Less in Size
Autorzy :
Tsunezuka, Y.
Shimizu, Y.
Tanaka, N.
Takayanagi, T.
Kawano, M.
Pokaż więcej
Źródło :
World Journal of Surgery: Official Journal of the International Society of Surgery/Société Internationale de Chirurgie. February 2007 31(2):314-317
Czasopismo naukowe
Tytuł :
1441P - Phase III study comparing bevacizumab plus erlotinib (BE) to erlotinib (E) in patients (pts) with untreated NSCLC harboring EGFR mutations: NEJ026
Autorzy :
Kawashima, Y.
Pokaż więcej
Źródło :
In Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19-23 October 2018, Munich, Germany, Annals of Oncology October 2018 29 Supplement 8
Czasopismo naukowe
Tytuł :
1403P - Open-label multicenter randomized phase II study of docetaxel plus bevacizumab or pemetrexed plus bevacizumab for elderly (≥75 years old) patients (pts) with previously untreated advanced non-squamous non-small cell lung cancer (NSCLC): TORG1323
Autorzy :
Honda, T.
Pokaż więcej
Źródło :
In Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19-23 October 2018, Munich, Germany, Annals of Oncology October 2018 29 Supplement 8
Czasopismo naukowe
Tytuł :
Closed three-port anatomic lobectomy with systematic nodal dissection for lung cancer
Autorzy :
Oda, M.
Ishikawa, N.
Tsunezuka, Y.
Matsumoto, I.
Tamura, M.
Kawakami, K.
Watanabe, G.
Pokaż więcej
Źródło :
Surgical Endoscopy: And Other Interventional TechniquesOfficial Journal of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and European Association for Endoscopic Surgery (EAES). August 2007 21(8):1464-1465
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies